FDA Investigator Myra L Gemmill
Myra L Gemmill has inspections in 1 countries as of 12 Oct 2023. Myra L Gemmill has collaborated with a combined 1573 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
12 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adams,
Addie V Scott Boston,
Amanda B Athey,
Andrew J Howard,
Anthony W Lee,
Aparna Tatavarthy,
Austin B Appler,
Barbara A Gullick,
Brandon J Brookens,
Brandon L Mariner,
Brian R Yaun,
Cassandra K Johnson,
Charlean R Butler,
Christine M O'leary,
Christopher R Richardson,
David A Carlson,
David A Trent Carlson,
David P Rice,
Debra D Devlieger,
Deshonna L Mitchell,
Dung N Tran,
Edette J Newby,
Edward P Potter,
Erin L Mcfiren,
Esaw,
Gale L Glinecki,
Gifford Whitehurst, Jr,
Heath R Harley,
Henry L Lennon,
Holly S Simms,
Jacqueline Johnson,
James M Simpson,
Jamie D Swann,
Janete F Guardia,
Jeffrey A Reed,
Jesse P Hardin,
Jessica D Nanini,
Jessica K Yoon,
Joanne S Wilson,
John Dan,
Joseph W Matthews,
Julie A Silberberg,
Justin A Hefferman,
Justin C Fuller,
Karen A Spencer,
Kenneth L Smalls,
Lara M Snyder,
Latoya S Oliver Powell,
Laurissa S Flowers,
LCDR Cornelius Brown, III,
LCDR Wilfred A Darang,
Marc A Jackson, Jr,
Margaret H Waters,
Marion W Nadeau,
Matthew M Henciak,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Reed,
Natasha A Dezinna,
Nicholas P Schaub,
Nina D Patel,
Normica G Facey,
Osama M Hamoud,
Patricia A Morrow,
Philip W Beck,
Pratik S Upadhyay, DDC,
Priya J Rathnam,
Rachel C Harrington,
Regina Gibson Melton,
Sean R Moynihan, MPH,
Shusheen A Alexander,
Sierra M Shockley,
State Agency,
Stephanie A Madison,
Stephen C Eason,
Tamara N Champion,
Teresa L Fox,
Theresa M Smedley,
Thomas,
Thomas J Hudson,
Thomas N Adjabeng,
Upendra Paudel,
Valeria A Moore,
Vincent T Duncan,
William D Murray,
Willy A Orantes
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more